AI assistant
Caplin Point Laboratories Ltd. — Call Transcript 2026
May 7, 2026
61439_rns_2026-05-07_7beffc98-5b83-49cb-97da-a208a9a524af.pdf
Call Transcript
Open in viewerOpens in your device viewer
CAPLIN POINT Laboratories
Caplin Point Laboratories Limited
Regd. office: Ashvich Tower, 3rd Floor,
No.3, Developed Plots Industrial Estate, Penungudi, Chennai – 600096.
Phone: +91 44 24968000 / +91 80127 72888 / +91 44 71148000
E-mail: [email protected] / Website: www.caplinpoint.net
CIN: L24231TN1990PLC019053
May 07, 2026
BSE Limited
Department of Corporate Relationship
1st Floor, New Trade Ring, Rotunda Building
Phiroze Jeejeebhoy Towers
Dalal Street, Mumbai- 400001
Scrip Code: 524742
National Stock Exchange of India Ltd
Department of Corporate Services
Exchange Plaza, 5th Floor,
C-1, Block G, Bandra Kurla Complex,
Bandra (E), Mumbai – 400 051
Scrip Code: CAPLIPOINT.
Dear Sir / Madam,
Sub : Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a post-results conference call with the analyst’s / fund houses/ investors will be held on Thursday, May 14, 2026, at 16:30 hrs. (IST) to discuss the financial performance of the Company for the quarter and year ended March 31, 2026.
A copy of the Conference Call Invitation is enclosed for your reference.
Kindly take the same on your records.
The schedule of the aforesaid meeting is subject to change due to exigencies on the part of Analyst / Company.
Sincerely Yours
For Caplin Point Laboratories Limited
VENKATRAM
GANAPATHISUB RAMANIAN
Digitally signed by
VENKATRAM
GANAPATHISUBRAMANIAN
Date: 2026.05.07 15:27:56
+05'30'
Venkatram G
General Counsel & Company Secretary
Membership No. A23989
Encl: A/a
Caplin Point Laboratories Limited
Caplin Point Laboratories Ltd. invites you to the Q4 & FY2026 Earnings
Conference Call on Thursday, May 14, 2026 at 16:30 hours IST
Caplin Point Laboratories Limited, a rapidly expanding and fully integrated pharmaceutical company, following its Q4 & FY2026 results announcement, invites you to the earnings conference call on Thursday, 14th May 2026 at 16:30 hours IST to discuss the financial results and business outlook.
The management team will be represented by:
- Mr. C.C. Paarthipan - Chairman
- Mr. Vivek Partheeban – Vice Chairman
- Dr. Sridhar Ganesan - MD
- Mr. D. Murlidharan – CFO
- Mr. Sathya Narayanan M – Deputy CFO
Earnings Conference Call on Thursday, 14th May 2026 at 16:30 hours IST
| Diamond Pass: | Click Here to Register for the Event |
|---|---|
| Universal Dial-In: | +91 22 6280 1222 |
| +91 22 7115 8123 | |
| International Toll-Free | Hong Kong: 800 964 448 |
| Singapore: 800 101 2045 | |
| USA: 1 866 746 2133 | |
| UK: 0 808 101 1573 |
Please register in advance for this earnings conference call using the above link to ensure that you are connected on time.
For any queries, please contact:
Churchgate Partners
Simran Malhotra / Soham Arora
+91 99454 72589
[email protected]
Churchgate Investor Relations
360 One CM Research
Mrs. Julie Mehta
+91 22 4031 7000
[email protected]
capital 360